David A Geller Selected Research

David A Geller Research Topics

Disease

49	Neoplasms (Cancer) 12/2022 - 05/2005
31	Reperfusion Injury 01/2021 - 07/2002
28	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 12/2005
21	Ischemia 01/2020 - 04/2005
15	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2005
11	Necrosis 01/2016 - 01/2005
10	Inflammation (Inflammations) 01/2020 - 04/2005
8	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 08/2003
8	Hypoxia (Hypoxemia) 12/2018 - 04/2003
6	Cholangiocarcinoma 10/2021 - 01/2008
5	Liver Neoplasms (Liver Cancer) 02/2016 - 01/2006
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2009
4	Disease Progression 01/2021 - 06/2011
4	Pain (Aches) 06/2011 - 05/2010
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
3	Fatigue 01/2020 - 05/2010
3	Fibrosis (Cirrhosis) 05/2017 - 01/2006
3	Hemorrhage 10/2014 - 01/2005
3	Wounds and Injuries (Trauma) 06/2008 - 01/2005
3	Sepsis (Septicemia) 04/2007 - 04/2005
2	Margins of Excision 01/2021 - 12/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 12/2012
2	Carcinogenesis 11/2013 - 05/2009
2	Liver Diseases (Liver Disease) 06/2012 - 03/2007
2	Hepatic Insufficiency 07/2011 - 01/2006
2	Gallstones (Gallstone) 03/2011 - 01/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2009 - 07/2006
2	Gram-Negative Bacterial Infections 04/2007 - 07/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

13	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2021 - 06/2006
11	CytokinesIBA 01/2021 - 05/2009
10	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2002
8	Alanine Transaminase (SGPT)IBA 01/2016 - 08/2005
7	Messenger RNA (mRNA)IBA 01/2021 - 12/2011
7	HMGB1 Protein (HMG1)IBA 07/2013 - 04/2005
5	CateninsIBA 06/2021 - 01/2010
5	Transcription Factors (Transcription Factor)IBA 06/2021 - 07/2002
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 05/2009
5	Carbon MonoxideIBA 12/2011 - 08/2005
4	InterferonsIBA 11/2021 - 01/2012
4	Adenosine Triphosphate (ATP)IBA 10/2020 - 03/2015
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2010
3	Biological ProductsIBA 12/2022 - 09/2010
3	Immune Checkpoint InhibitorsIBA 11/2021 - 09/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2014
3	Interferon Regulatory FactorsIBA 01/2021 - 09/2012
3	MicroRNAs (MicroRNA)IBA 10/2020 - 07/2012
3	Yttrium-90IBA 06/2015 - 11/2008
3	NF-kappa B (NF-kB)IBA 05/2009 - 07/2002
3	beta CateninIBA 05/2009 - 07/2006
2	Deoxyribonucleases (DNase)FDA Link 01/2021 - 11/2019
2	AntigensIBA 04/2014 - 08/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2013 - 07/2006
2	Toll-Like Receptor 4IBA 07/2013 - 11/2007
2	JNK Mitogen-Activated Protein KinasesIBA 07/2013 - 08/2003
2	InterleukinsIBA 06/2012 - 05/2009
2	Narcotics (Narcotic Analgesics)IBA 07/2011 - 12/2010
2	Arginine (L-Arginine)FDA Link 08/2008 - 02/2007
2	ArginaseIBA 08/2008 - 02/2007
2	LipopolysaccharidesIBA 04/2007 - 07/2002
2	Transaminases (Aminotransferases)IBA 10/2006 - 01/2005
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2006 - 08/2005
1	Interleukin-33IBA 01/2022
1	hydroxide ionIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	lenvatinibIBA 06/2021
1	Checkpoint Kinase 1IBA 01/2021
1	ChemokinesIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	atezolizumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	IpilimumabIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	GelatinIBA 05/2020
1	PlasticsIBA 05/2020
1	CEACAM1 ProteinIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 11/2019

Therapy/Procedure

27	Liver Transplantation 01/2021 - 07/2002
16	Therapeutics 01/2021 - 05/2005
13	Hepatectomy 01/2022 - 11/2009
7	Drug Therapy (Chemotherapy) 12/2022 - 07/2005
5	Radiofrequency Ablation 01/2016 - 08/2008
4	Length of Stay 07/2011 - 01/2009
3	Immunotherapy 01/2022 - 01/2020
3	Palliative Care (Palliative Therapy) 04/2016 - 07/2005
3	Transplantation 10/2011 - 01/2005
2	Neoadjuvant Therapy 01/2021 - 01/2012
2	Metastasectomy 05/2012 - 11/2009
2	Laparoscopic Cholecystectomy 03/2011 - 01/2009
2	Contraindications 03/2011 - 12/2009
2	Warm Ischemia 01/2007 - 12/2005
2	Microspheres (Microsphere) 07/2005 - 06/2005
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Operative Surgical Procedures 06/2021